Literature DB >> 33755791

Carotid plaque inflammatory activity assessed by 2-[18F]FDG-PET imaging decrease after a neurological thromboembolic event.

Laerke Urbak1, Rasmus S Ripa2, Benjamin V Sandholt3, Andreas Kjaer2, Henrik Sillesen3, Martin Graebe3.   

Abstract

BACKGROUND: Atherosclerotic plaque vulnerability is comprised by plaque composition driven by inflammatory activity and these features can be depicted with 3D ultrasound and 2-[18F]FDG-PET, respectively. The study investigated timely changes in carotid artery plaque inflammation and morphology after a thromboembolic event with PET/CT and novel ultrasound volumetric grayscale median (GSM) readings. Patients with a single hemisphere-specific neurological symptom and the presence of an ipsilateral carotid artery atherosclerotic plaque were prospectively included to both 2-[18F]FDG PET/CT and 3D ultrasound scans of the plaque immediately after their event and again three months later. On PET/CT images the maximum standardized uptake value (SUVmax) was measured and the volumetric ultrasound acquisitions were analyzed using a semiautomated software measuring GSM values.
RESULTS: Baseline scans were performed by a mean of 7 days (range 2-14) after the symptom and again after 98 days (range 91-176). For the entire group (n = 14), we found a decrease in average SUVmax from baseline to follow-up of - 0.18 (95% confidence interval: - 0.34 to - 0.02, P = 0.034). GSM did not increase significantly over time (mean change: + 2.21, 95% confidence interval: - 17.02 to 21.44, P = 0.808).
CONCLUSION: A decrease in culprit lesion 2-[18F]FDG-uptake 3 months after an event indicates a decrease in inflammatory activity, suggesting that carotid plaque stabilization over time. 3D ultrasound morphological quantitative differences in GSM were not detectable after 3 months.

Entities:  

Keywords:  3D ultrasound; Carotid artery plaque; FDG PET; Inflammation; Vulnerable plaque

Year:  2021        PMID: 33755791      PMCID: PMC7988031          DOI: 10.1186/s13550-021-00773-y

Source DB:  PubMed          Journal:  EJNMMI Res        ISSN: 2191-219X            Impact factor:   3.138


  38 in total

1.  Relation of the site of acute myocardial infarction to the most severe coronary arterial stenosis at prior angiography.

Authors:  D Giroud; J M Li; P Urban; B Meier; W Rutishauer
Journal:  Am J Cardiol       Date:  1992-03-15       Impact factor: 2.778

2.  Macrophages are associated with lipid-rich carotid artery plaques, echolucency on B-mode imaging, and elevated plasma lipid levels.

Authors:  Marie-Louise M Grønholdt; Børge G Nordestgaard; Jacob Bentzon; Britt M Wiebe; Ji Zhou; Erling Falk; Henrik Sillesen
Journal:  J Vasc Surg       Date:  2002-01       Impact factor: 4.268

3.  Lipid-rich carotid artery plaques appear echolucent on ultrasound B-mode images and may be associated with intraplaque haemorrhage.

Authors:  M L Grønholdt; B M Wiebe; H Laursen; T G Nielsen; T V Schroeder; H Sillesen
Journal:  Eur J Vasc Endovasc Surg       Date:  1997-12       Impact factor: 7.069

4.  Clinical Relevance of 18F-Sodium Fluoride Positron-Emission Tomography in Noninvasive Identification of High-Risk Plaque in Patients With Coronary Artery Disease.

Authors:  Joo Myung Lee; Ji-In Bang; Bon-Kwon Koo; Doyeon Hwang; Jonghanne Park; Jinlong Zhang; Tong Yaliang; Minseok Suh; Jin Chul Paeng; Yasutsugu Shiono; Takashi Kubo; Takashi Akasaka
Journal:  Circ Cardiovasc Imaging       Date:  2017-11       Impact factor: 7.792

5.  Inter-Scan Reproducibility of Carotid Plaque Volume Measurements by 3-D Ultrasound.

Authors:  Benjamin V Sandholt; Antoine Collet-Billon; Robert Entrekin; Henrik H Sillesen
Journal:  Ultrasound Med Biol       Date:  2017-12-25       Impact factor: 2.998

6.  Gene expression and 18FDG uptake in atherosclerotic carotid plaques.

Authors:  Sune Folke Pedersen; Martin Graebe; Anne Mette Fisker Hag; Liselotte Højgaard; Henrik Sillesen; Andreas Kjaer
Journal:  Nucl Med Commun       Date:  2010-05       Impact factor: 1.690

7.  When to image carotid plaque inflammation with FDG PET/CT.

Authors:  Martin Graebe; Lise Borgwardt; Liselotte Højgaard; Henrik Sillesen; Andreas Kjaer
Journal:  Nucl Med Commun       Date:  2010-09       Impact factor: 1.690

Review 8.  Coronary plaque disruption.

Authors:  E Falk; P K Shah; V Fuster
Journal:  Circulation       Date:  1995-08-01       Impact factor: 29.690

9.  Carotid Plaque Inflammation Imaged by 18F-Fluorodeoxyglucose Positron Emission Tomography and Risk of Early Recurrent Stroke.

Authors:  Peter J Kelly; Pol Camps-Renom; Nicola Giannotti; Joan Martí-Fàbregas; Sean Murphy; Jonathan McNulty; Mary Barry; Patrick Barry; David Calvet; Shelagh B Coutts; Simon Cronin; Raquel Delgado-Mederos; Eamon Dolan; Alejandro Fernández-León; Shane Foley; Joseph Harbison; Gillian Horgan; Eoin Kavanagh; Michael Marnane; Ciaran McDonnell; Martin O'Donohoe; Vijay Sharma; Cathal Walsh; David Williams; Martin O'Connell
Journal:  Stroke       Date:  2019-06-06       Impact factor: 7.914

10.  Pioglitazone attenuates atherosclerotic plaque inflammation in patients with impaired glucose tolerance or diabetes a prospective, randomized, comparator-controlled study using serial FDG PET/CT imaging study of carotid artery and ascending aorta.

Authors:  Minori Mizoguchi; Nobuhiro Tahara; Atsuko Tahara; Yoshikazu Nitta; Norihiro Kodama; Toyoharu Oba; Kazutoshi Mawatari; Hideo Yasukawa; Hayato Kaida; Masatoshi Ishibashi; Naofumi Hayabuchi; Haruhito Harada; Hisao Ikeda; Sho-Ichi Yamagishi; Tsutomu Imaizumi
Journal:  JACC Cardiovasc Imaging       Date:  2011-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.